$ASPI
ASP Isotopes Inc. Stock $aspi

$aspi Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000147793224005128 Filed on August 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$1.088M	$1.022M	$0.00
YoY Change
Cost Of Revenue	$793.7K	$601.3K	$0.00
YoY Change
Gross Profit	$294.0K	$421.0K	$0.00
YoY Change
Gross Profit Margin	27.03%	41.18%
Selling, General & Admin	$4.693M	$7.405M	$4.095M
YoY Change	26.5%	80.85%	230.28%
% of Gross Profit	1596.42%	1758.85%
Research & Development	$1.034M	$473.3K	$252.9K
YoY Change	332.46%	87.16%	-43.36%
% of Gross Profit	351.88%	112.42%
Depreciation & Amortization	$175.9K	$146.5K	$167.00
YoY Change	21835.16%	87624.55%
% of Gross Profit	59.84%	34.8%
Operating Expenses	$5.728M	$7.878M	$4.348M
YoY Change	45.13%	81.22%	157.83%
Operating Profit	-$5.434M	-$7.457M	-$4.348M
YoY Change	37.68%	71.53%	425.09%
Interest Expense	-$2.312M	$69.08K	$1.100K
YoY Change		6179.82%	-24.14%
% of Operating Profit
Other Income/Expense, Net	-$1.930M	-$1.410M	$61.20K
YoY Change	599.39%	-2404.35%	7656.4%
Pretax Income	-$7.364M	-$8.868M	-$4.286M
YoY Change	74.5%	106.88%	154.42%
Income Tax	-$8.370K	$13.77K	$0.00
% Of Pretax Income
Net Earnings	-$7.355M	-$8.881M	-$4.286M
YoY Change	74.2%	107.2%	154.42%
Net Earnings / Revenue	-676.24%	-868.77%
Basic Earnings Per Share	-$0.12	-$0.24	-$0.14
Diluted Earnings Per Share	-$0.12	-$0.24	-$0.14
COMMON SHARES
Basic Shares Outstanding	66.69M shares	48.92M shares	37.39M shares
Diluted Shares Outstanding	61.53M

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.57M	$28.26M	$3.626M
YoY Change	2152.03%	679.4%	28.89%
Cash & Equivalents	$51.57M	$28.26M	$3.626M
Short-Term Investments
Other Short-Term Assets	$3.872M	$3.293M	$404.4K
YoY Change	780.1%	714.46%	-45.62%
Inventory	$84.85K
Prepaid Expenses
Receivables	$560.4K	$515.5K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$56.09M	$32.07M	$4.031M
YoY Change	1955.59%	695.71%	13.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.98M	$17.77M	$7.735M
YoY Change	175.36%	129.79%	19.55%
Goodwill	$3.461M	$3.289M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$229.9K	$208.4K	$342.7K
YoY Change	32.38%	-39.19%
Total Long-Term Assets	$28.04M	$22.69M	$8.720M
YoY Change	206.65%	160.2%	34.78%
TOTAL ASSETS
Total Short-Term Assets	$56.09M	$32.07M	$4.031M
Total Long-Term Assets	$28.04M	$22.69M	$8.720M
Total Assets	$84.13M	$54.76M	$12.75M
YoY Change	608.64%	329.47%	27.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.798M	$2.433M	$670.1K
YoY Change	347.2%	263.08%	-23.8%
Accrued Expenses	$1.762M	$2.456M	$807.6K
YoY Change	61.35%	204.04%	22.09%
Deferred Revenue
YoY Change
Short-Term Debt	$33.45K	$31.61K	$33.85K
YoY Change	11.5%	-6.62%	0.0%
Long-Term Debt Due	$695.2K	$120.6K
YoY Change
Total Short-Term Liabilities	$7.426M	$8.011M	$1.949M
YoY Change	185.44%	311.05%	7.34%
LONG-TERM LIABILITIES
Long-Term Debt	$33.69M	$29.65M	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$1.653M	$648.2K
YoY Change	-100.0%	155.02%	-19.26%
Total Long-Term Liabilities	$0.00	$1.653M	$648.2K
YoY Change	-100.0%	155.02%	-19.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.426M	$8.011M	$1.949M
Total Long-Term Liabilities	$0.00	$1.653M	$648.2K
Total Liabilities	$42.11M	$40.40M	$2.597M
YoY Change	1203.08%	1455.55%	-0.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.99M	-$39.72M	-$15.45M
YoY Change	138.81%	157.01%
Common Stock	$684.1K	$521.3K	$373.9K
YoY Change	78.39%	39.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.70M	$11.01M	$10.15M
YoY Change
Total Liabilities & Shareholders Equity	$84.13M	$54.76M	$12.75M
YoY Change	608.64%	329.47%	27.16%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$7.355M	-$8.881M	-$4.286M
YoY Change	74.2%	107.2%	154.42%
Depreciation, Depletion And Amortization	$175.9K	$146.5K	$167.00
YoY Change	21835.16%	87624.55%
Cash From Operating Activities	-$4.840M	-$5.125M	-$1.257M
YoY Change	633.38%	307.73%	-9.15%
INVESTING ACTIVITIES
Capital Expenditures	$4.485M	$2.622M	$146.6K
YoY Change	559.49%	1689.2%	-91.54%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$4.485M	-$2.622M	-$146.6K
YoY Change	559.49%	1689.2%	-91.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	32.43M	12.15M	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-4.840M	-5.125M	-1.257M
Cash From Investing Activities	-4.485M	-2.622M	-146.6K
Cash From Financing Activities	32.43M	12.15M	0.000
Net Change In Cash	23.10M	4.404M	-1.403M
YoY Change	-1823.99%	-413.8%	428.41%
FREE CASH FLOW
Cash From Operating Activities	-$4.840M	-$5.125M	-$1.257M
Capital Expenditures	$4.485M	$2.622M	$146.6K
Free Cash Flow	-$9.325M	-$7.747M	-$1.403M
YoY Change	595.88%	451.98%	-54.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52132833	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48923276	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company’s condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of the Company’s condensed consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and disclosure in the Company’s condensed consolidated financial statements and accompanying notes. The most significant estimates in the Company’s consolidated financial statements relate to stock based compensation, the accounting for the acquisition of PET Labs Pharmaceuticals and fair value measurement of the convertible notes payable and warrants. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, actual results may materially differ from these estimates and assumptions.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Cash balances maintained at U.S. financial institutions may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit of $250,000 per depositor, per insured bank for each account ownership category. Although the Company currently believes that the financial institutions with whom it does business, will be able to fulfill their commitments to the Company, there is no assurance that those institutions will be able to continue to do so. The Company has not experienced any credit losses associated with its balances in such accounts for the six months ended June 30, 2024 and 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our foreign subsidiaries held cash of approximately $1,885,000 and $1,963,000 as of June 30, 2024 and December 31, 2023, respectively, which is included in cash on the consolidated balance sheets. Our strategic plan does not require the repatriation of foreign cash in order to fund our operations in the U.S., and it is our current intention to indefinitely reinvest our foreign cash outside of the U.S. If we were to repatriate foreign cash to the U.S., we would be required to accrue and pay U.S. taxes in accordance with applicable U.S. tax rules and regulations as a result of the repatriation.</p>
	dei	Entity Central Index Key EntityCentralIndexKey	0001921865
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48923276	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52132833	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	36530	usd
CY2023Q4	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	1821021	usd
	aspi	Cash Director Fees CashDirectorFees	240000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41555
	dei	Entity Registrant Name EntityRegistrantName	ASP Isotopes Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2618235
	dei	Entity Address Address Line1 EntityAddressAddressLine1	601 Pennsylvania Avenue NW
	dei	Entity Address Address Line2 EntityAddressAddressLine2	South Building
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 900
	dei	Entity Address City Or Town EntityAddressCityOrTown	Washington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	DC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20004
	dei	City Area Code CityAreaCode	202
	dei	Local Phone Number LocalPhoneNumber	756-2245
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01per share
	dei	Trading Symbol TradingSymbol	ASPI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	66686941	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28262332	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7908181	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	515450	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	216504	usd
CY2024Q2	aspi	Receivable From Noncontrolling Interests Current ReceivableFromNoncontrollingInterestsCurrent	0	usd
CY2023Q4	aspi	Receivable From Noncontrolling Interests Current ReceivableFromNoncontrollingInterestsCurrent	721548	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3248432	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1664023	usd
CY2024Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	45000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	32071214	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	10510256	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17774788	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10712839	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1417402	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1258701	usd
CY2024Q2	us-gaap	Goodwill Goodwill	3289163	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3267103	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	208367	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1793014	usd
CY2024Q2	us-gaap	Assets Assets	54760934	usd
CY2023Q4	us-gaap	Assets Assets	27541913	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2432857	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1111819	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2455510	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1311245	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	31610	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	470396	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	120595	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	61941	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	541796	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	336564	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	882000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	882000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1240724	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1500000	usd
CY2024Q2	aspi	Fair Value Of Shares Issuable FairValueOfSharesIssuable	306000	usd
CY2023Q4	aspi	Fair Value Of Shares Issuable FairValueOfSharesIssuable	0	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8011092	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5673965	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	71093	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	110578	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	29086669	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	562566	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	207092	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1014774	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1066647	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1653000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1653000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	40399194	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8711282	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	521329	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	489233	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50911752	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40567003	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39720310	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23839300	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-701291	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-920982	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	11011480	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16295954	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	3350260	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	2534677	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14361740	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18830631	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54760934	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27541913	usd
CY2024Q2	us-gaap	Revenues Revenues	1022299	usd
CY2023Q2	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	1862653	usd
	us-gaap	Revenues Revenues	0	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	601275	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1162759	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	421024	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	0	usd
	us-gaap	Gross Profit GrossProfit	699894	usd
	us-gaap	Gross Profit GrossProfit	0	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	473302	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	252880	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	688436	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	460214	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7405178	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4094664	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13283724	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7612154	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	7878480	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	4347544	usd
	us-gaap	Operating Expenses OperatingExpenses	13972160	usd
	us-gaap	Operating Expenses OperatingExpenses	8072368	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7457456	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4347544	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13272266	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8072368	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	26147	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1804	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-935	usd
CY2024Q2	aspi	Gain Loss Change In Fair Value Of Share Liability GainLossChangeInFairValueOfShareLiability	164000	usd
CY2023Q2	aspi	Gain Loss Change In Fair Value Of Share Liability GainLossChangeInFairValueOfShareLiability	60100	usd
	aspi	Gain Loss Change In Fair Value Of Share Liability GainLossChangeInFairValueOfShareLiability	-54000	usd
	aspi	Gain Loss Change In Fair Value Of Share Liability GainLossChangeInFairValueOfShareLiability	170385	usd
CY2024Q2	aspi	Gain Loss Change In Fair Value Of Convertible Notes Payable GainLossChangeInFairValueOfConvertibleNotesPayable	-1574816	usd
CY2023Q2	aspi	Gain Loss Change In Fair Value Of Convertible Notes Payable GainLossChangeInFairValueOfConvertibleNotesPayable	0	usd
	aspi	Gain Loss Change In Fair Value Of Convertible Notes Payable GainLossChangeInFairValueOfConvertibleNotesPayable	-2528526	usd
	aspi	Gain Loss Change In Fair Value Of Convertible Notes Payable GainLossChangeInFairValueOfConvertibleNotesPayable	0	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	43530	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	1098	usd
	us-gaap	Interest Income Other InterestIncomeOther	55718	usd
	us-gaap	Interest Income Other InterestIncomeOther	1494	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	69078	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	82866	usd
	us-gaap	Interest Expense InterestExpense	0	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1410217	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	61198	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2607870	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	170944	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8867673	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4286346	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15880136	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7901424	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13769	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-33850	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-8881442	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4286346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15846286	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7901424	usd
CY2024Q2	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	51483	usd
CY2023Q2	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	34724	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-8932925	usd
CY2023Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-4286346	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-15881010	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-7901424	usd
CY2024Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2779659	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2779659	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2024Q2	aspi	Net Loss Attributable To Asp Isotopes Inc Shareholders NetLossAttributableToAspIsotopesIncShareholders	-11712584	usd
CY2023Q2	aspi	Net Loss Attributable To Asp Isotopes Inc Shareholders NetLossAttributableToAspIsotopesIncShareholders	-4286346	usd
	aspi	Net Loss Attributable To Asp Isotopes Inc Shareholders NetLossAttributableToAspIsotopesIncShareholders	-18660669	usd
	aspi	Net Loss Attributable To Asp Isotopes Inc Shareholders NetLossAttributableToAspIsotopesIncShareholders	-7901424	usd
CY2024Q2	aspi	Earnings Per Share Basic And Diluteds EarningsPerShareBasicAndDiluteds	-0.24
CY2023Q2	aspi	Earnings Per Share Basic And Diluteds EarningsPerShareBasicAndDiluteds	-0.14
	aspi	Earnings Per Share Basic And Diluteds EarningsPerShareBasicAndDiluteds	-0.40
	aspi	Earnings Per Share Basic And Diluteds EarningsPerShareBasicAndDiluteds	-0.27
CY2024Q2	aspi	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	49136009	shares
CY2023Q2	aspi	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	29796065	shares
	aspi	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	46848926	shares
	aspi	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	29535060	shares
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-8881442	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-4286346	usd
	us-gaap	Profit Loss ProfitLoss	-15846286	usd
	us-gaap	Profit Loss ProfitLoss	-7901424	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	763420	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-472673	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	219691	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1476526	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8118022	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4759019	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15626595	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9377950	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	52303	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	44773	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8170325	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4759019	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15671368	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9377950	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18830631	usd
CY2024Q1	aspi	Retired Unvested Restricted Shares Amount RetiredUnvestedRestrictedSharesAmount	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1713654	usd
CY2024Q1	aspi	Distribution To Noncontrolling Interest Of Variable Interest Entity DistributionToNoncontrollingInterestOfVariableInterestEntity	-8694	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-543729	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6964844	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13027018	usd
CY2024Q2	aspi	Issuance Of Common Stock From Warrant Exercise Amount IssuanceOfCommonStockFromWarrantExerciseAmount	5537975	usd
CY2024Q2	aspi	Issuance Of Restricted Common Stock Amount IssuanceOfRestrictedCommonStockAmount	0	usd
CY2024Q2	aspi	Issuance Of Common Stock To Consultant Amount IssuanceOfCommonStockToConsultantAmount	183600	usd
CY2024Q2	aspi	Settlement Of Liabilities With Consultants Amount SettlementOfLiabilitiesWithConsultantsAmount	183600	usd
CY2024Q2	aspi	Board Fee Liabilities To Be Settled With Shares BoardFeeLiabilitiesToBeSettledWithShares	240000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2518016	usd
CY2024Q2	aspi	Contribution From Noncontrolling Interest In Vie ContributionFromNoncontrollingInterestInVie	807975	usd
CY2024Q2	aspi	Distribution To Noncontrolling Interest Of Variable Interest Entity DistributionToNoncontrollingInterestOfVariableInterestEntity	-18422	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	763420	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-8881442	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14361740	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9817461	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4493610	usd
CY2023Q1	aspi	Cancellation Of Common Stock Received In Exchange For Issuance Of Preferred Stock In Subsidiary Amount CancellationOfCommonStockReceivedInExchangeForIssuanceOfPreferredStockInSubsidiaryAmount	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	75570	usd
CY2023Q1	aspi	Issuance Of Restricted Common Stock Amount IssuanceOfRestrictedCommonStockAmount	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2144099	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1003853	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3615078	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11911809	usd
CY2023Q2	aspi	Settlement Of Liabilities With Related Party SettlementOfLiabilitiesWithRelatedParty	626223	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2374686	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-472673	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4286346	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10153699	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15846286	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7901424	usd
	us-gaap	Depreciation Depreciation	249714	usd
	us-gaap	Depreciation Depreciation	167	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1666	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4231670	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4518785	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	621915	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
	aspi	Share Liability For Non Cash Consultant Expense ShareLiabilityForNonCashConsultantExpense	619200	usd
	aspi	Share Liability For Non Cash Consultant Expense ShareLiabilityForNonCashConsultantExpense	496300	usd
	aspi	Gain Loss Change In Fair Value Of Share Liability GainLossChangeInFairValueOfShareLiability	-54000	usd
	aspi	Gain Loss Change In Fair Value Of Share Liability GainLossChangeInFairValueOfShareLiability	170385	usd
	aspi	Gain Loss Change In Fair Value Of Convertible Notes Payable GainLossChangeInFairValueOfConvertibleNotesPayable	-2528526	usd
	aspi	Gain Loss Change In Fair Value Of Convertible Notes Payable GainLossChangeInFairValueOfConvertibleNotesPayable	0	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	217997	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	32553	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-39068	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-288878	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1566707	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	294971	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-48747	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	223828	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-351830	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1425242	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	446564	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-224134	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-18844	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-303941	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8095256	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2701890	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3867903	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	508607	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3867903	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-508607	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5537975	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000	usd
	aspi	Proceeds From Noncontrolling Interest In Variable Interest Entities ProceedsFromNoncontrollingInterestInVariableInterestEntities	807975	usd
	aspi	Proceeds From Noncontrolling Interest In Variable Interest Entities ProceedsFromNoncontrollingInterestInVariableInterestEntities	0	usd
	aspi	Proceeds From Collection Of Receivable From Noncontrolling Interest In Vie ProceedsFromCollectionOfReceivableFromNoncontrollingInterestInVie	705403	usd
	aspi	Proceeds From Collection Of Receivable From Noncontrolling Interest In Vie ProceedsFromCollectionOfReceivableFromNoncontrollingInterestInVie	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	506390	usd
	aspi	Payment Of Deferred Issuance Costs PaymentOfDeferredIssuanceCosts	-45000	usd
	aspi	Payment Of Deferred Issuance Costs PaymentOfDeferredIssuanceCosts	0	usd
	aspi	Repayments Of Distribution To Noncontrolling Interest In Variable Interest Entities RepaymentsOfDistributionToNoncontrollingInterestInVariableInterestEntities	27116	usd
	aspi	Repayments Of Distribution To Noncontrolling Interest In Variable Interest Entities RepaymentsOfDistributionToNoncontrollingInterestInVariableInterestEntities	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	25936228	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	438569	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	61929	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32414967	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4493610	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20451808	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1283113	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-97657	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-46088	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7908181	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2389140	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28262332	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3626165	usd
	aspi	Settlement Of Share Liability SettlementOfShareLiability	0	usd
	aspi	Settlement Of Share Liability SettlementOfShareLiability	626223	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	364458	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	501389	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	aspi	Purchase Of Property And Equipment Included In Accounts Payable PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable	1100179	usd
	aspi	Purchase Of Property And Equipment Included In Accounts Payable PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable	318900	usd
	aspi	Payment To Acquire Property And Equipment Included In Other Noncurrent Liabilities PaymentToAcquirePropertyAndEquipmentIncludedInOtherNoncurrentLiabilities	1653000	usd
	aspi	Payment To Acquire Property And Equipment Included In Other Noncurrent Liabilities PaymentToAcquirePropertyAndEquipmentIncludedInOtherNoncurrentLiabilities	0	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2779659	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
	aspi	Board Fees To Be Settled With Common Stock BoardFeesToBeSettledWithCommonStock	240000	usd
	aspi	Board Fees To Be Settled With Common Stock BoardFeesToBeSettledWithCommonStock	0	usd
	aspi	Issuance Of Common Stock In Lieu Of Commissions IssuanceOfCommonStockInLieuOfCommissions	0	usd
	aspi	Issuance Of Common Stock In Lieu Of Commissions IssuanceOfCommonStockInLieuOfCommissions	75750	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	15846286	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	7901424	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28262332	usd
CY2024Q2	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2024Q2	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	1885000	usd
CY2023Q4	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	1963000	usd
CY2024Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	146500	usd
CY2024Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	306000	usd
	aspi	Fair Value Asset Recurring Basis Still Held Unrealized Gain Loss FairValueAssetRecurringBasisStillHeldUnrealizedGainLoss	29086669	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	140455	usd
CY2023	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	669700	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	194540	usd
CY2023	aspi	Hgu hgu	-1004695	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	435600	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	54000	usd
	aspi	Hgu hgu	-183600	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	306000	usd
	aspi	Business Acquisition Percentage Of Interests Acquired BusinessAcquisitionPercentageOfInterestsAcquired	0.51	pure
	aspi	Business Acquisition Percentage Of Interests Acquired BusinessAcquisitionPercentageOfInterestsAcquired	0.51	pure
CY2024Q2	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	1022299	usd
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	1862653	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	216504	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	1862653	usd
	aspi	Revenue Deductions RevenueDeductions	-1563707	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	515450	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18050916	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10750546	usd
CY2024Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	276128	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	37707	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17774788	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10712839	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	948470	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	447295	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1375950	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	845344	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	131090	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18606	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2455510	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1311245	usd
CY2024Q1	aspi	Fair Value Of Additional Liability FairValueOfAdditionalLiability	21063748	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	20550000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	513748	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	521423	usd
CY2024Q2	aspi	Fair Value Of Additional Liability FairValueOfAdditionalLiability	5494395	usd
CY2024Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5386228	usd
CY2024Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	108167	usd
	aspi	Description Of Annual Interest Rate DescriptionOfAnnualInterestRate	The Convertible Notes are payable on demand in March 2029 and bear an annual interest rate of 6% through March 7, 2025 and 8% thereafter.
	aspi	Fair Value Of Additional Liability FairValueOfAdditionalLiability	21063748	usd
	aspi	Issuance Of Convertible Notes IssuanceOfConvertibleNotes	5494395	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	29086669	usd
	aspi	Fair Value Of Convertible Notes Payable Increase Decrease FairValueOfConvertibleNotesPayableIncreaseDecrease	2528526	usd
	aspi	Other Income And Expenses OtherIncomeAndExpenses	1574816	usd
CY2024Q2	aspi	Total Principal And Accrued Interest Of The Convertible Notes TotalPrincipalAndAccruedInterestOfTheConvertibleNotes	26978913	usd
CY2024Q2	aspi	Accrued Interest AccruedInterest	420770	usd
CY2024Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	31610	usd
CY2023Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	31827	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	526282	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0874	pure
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	4499	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	11247	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	1653000	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	1653000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	6050000	usd
CY2023Q2	us-gaap	Loss Contingency Receivable Proceeds LossContingencyReceivableProceeds	626223	usd
	us-gaap	Net Investment In Lease Sale NetInvestmentInLeaseSale	2200000	usd
	us-gaap	Legal Fees LegalFees	78304	usd
	aspi	Summary Of Long Leases In The Condensed Consolidated Balance Sheet Table Textblock SummaryOfLongLeasesInTheCondensedConsolidatedBalanceSheetTableTextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ROU Asset </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Operating Lease Liability - Current</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Operating Lease Liability – Non-Current </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Operating Lease Liability</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Lease:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office and laboratory, Pretoria, South Africa</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">595,655</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">59,746</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">611,220</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">670,966</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additional production, Pretoria, South Africa</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">306,197</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">177,221</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">128,976</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">306,197</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Laboratory, Pretoria, South Africa</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,177</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22,059</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,424</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">59,483</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office and production, Pretoria, South Africa</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">457,373</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">282,770</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">237,154</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">519,924</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,417,402</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">541,796</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,014,774</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,556,570</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ROU Asset </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Operating Lease Liability - Current</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Operating Lease Liability – Non-Current </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Operating Lease Liability</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Lease:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office and laboratory, Pretoria, South Africa</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">626,548</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">53,504</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">637,348</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">690,852</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Laboratory, Pretoria, South Africa</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">68,089</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,608</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">48,805</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">68,413</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office and production, Pretoria, South Africa</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">564,064</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">263,452</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">380,494</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">643,946</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,258,701</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">336,564</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,066,647</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,403,211</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1417402	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	541796	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1014774	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1556570	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1258701	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	336564	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1066647	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1403211	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	43205	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	15762	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	36530	usd
CY2022Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	100000	usd
CY2022Q1	aspi	Royalty Percentage On Sale Of Products RoyaltyPercentageOnSaleOfProducts	0.10	pure
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6000000	zar
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	354000	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	626223	usd
CY2023Q4	aspi	Business Combination Consideration Transferred Cash And Equivalents BusinessCombinationConsiderationTransferredCashAndEquivalents	500000	usd
CY2023Q4	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	1395348	usd
CY2023Q4	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	1895348	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	378152	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	460165	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	184457	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	821926	usd
CY2023Q4	aspi	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Right Of Use Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets	592304	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities	1248699	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation	677163	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	511142	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3205227	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	1895348	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3205227	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3205227	usd
CY2023Q4	aspi	Goodwill Translation Adjustment GoodwillTranslationAdjustment	61876	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3267103	usd
CY2024Q1	aspi	Goodwill Translation Adjustment GoodwillTranslationAdjustment	22060	usd
CY2024Q1	us-gaap	Goodwill Goodwill	3289163	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52132833	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48923276	shares
	aspi	Cash Director Fees CashDirectorFees	240000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.603	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0344	pure
CY2023Q1	aspi	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm	P5Y6M
CY2023Q1	aspi	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionExpectedDividendRate	0	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.735	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0437	pure
CY2024Q2	aspi	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm	P5Y6M
CY2024Q2	aspi	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	6000000	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	5000000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2766000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.91
	aspi	Weighted Average Remaining Contractual Term In Years Beginning WeightedAverageRemainingContractualTermInYearsBeginning	P8Y4M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	231000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	35000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.00
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2731000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.90
	aspi	Weighted Average Remaining Contractual Term In Years Ending WeightedAverageRemainingContractualTermInYearsEnding	P7Y10M24D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3157360	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1996623	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.88
	aspi	Weighted Average Remaining Contractual Term In Years Exercisable WeightedAverageRemainingContractualTermInYearsExercisable	P7Y10M24D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2356120	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2731000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.90
	aspi	Weighted Average Remaining Contractual Term In Years Vested Or Expected To Vest WeightedAverageRemainingContractualTermInYearsVestedOrExpectedToVest	P7Y10M24D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3157360	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	100000	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	978466	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4489186	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	250000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1864186	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.54
	aspi	Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeited And Retiredinperiod SharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedAndRetiredinperiod	325000	shares
	aspi	Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeited And Retiredinperiodweightedaveragegrantdatefairvalue SharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedAndRetiredinperiodweightedaveragegrantdatefairvalue	1.19
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2550000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.45
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2518016	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2374686	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4231670	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4518785	usd
CY2024Q2	aspi	Net Loss Before Deemed Dividend NetLossBeforeDeemedDividend	-8932925	usd
CY2023Q2	aspi	Net Loss NetLoss	-4286346	usd
	aspi	Net Loss Before Deemed Dividend NetLossBeforeDeemedDividend	-15881010	usd
	aspi	Net Loss NetLoss	-7901424	usd
CY2024Q2	aspi	Deemed Dividend On Warrant To Purchase Common Stock DeemedDividendOnWarrantToPurchaseCommonStock	-2779659	usd
CY2023Q2	aspi	Deemed Dividend On Warrant To Purchase Common Stock DeemedDividendOnWarrantToPurchaseCommonStock	0	usd
	aspi	Deemed Dividend On Warrant To Purchase Common Stock DeemedDividendOnWarrantToPurchaseCommonStock	-2779659	usd
	aspi	Deemed Dividend On Warrant To Purchase Common Stock DeemedDividendOnWarrantToPurchaseCommonStock	0	usd
CY2024Q2	aspi	Net Loss NetLoss	-11712584	usd
CY2023Q2	aspi	Net Loss Before Deemed Dividend NetLossBeforeDeemedDividend	-4286346	usd
	aspi	Net Loss NetLoss	-18660669	usd
	aspi	Net Loss Before Deemed Dividend NetLossBeforeDeemedDividend	-7901424	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	49136009	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29796065	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	46848926	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29535060	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2731000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2851000	shares
CY2024Q2	aspi	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	1446519	shares
CY2023Q2	aspi	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	3386076	shares
CY2024Q2	aspi	Unvested Restricted Stock UnvestedRestrictedStock	2550000	shares
CY2023Q2	aspi	Unvested Restricted Stock UnvestedRestrictedStock	6867562	shares
CY2024Q2	aspi	Shares Of Common Stock Equivalents SharesOfCommonStockEquivalents	6727519	shares
CY2023Q2	aspi	Shares Of Common Stock Equivalents SharesOfCommonStockEquivalents	13104638	shares
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.002	pure

Files In Submission

Name	View Source	Status
0001477932-24-005128-index-headers.html	Edgar Link	pending
0001477932-24-005128-index.html	Edgar Link	pending
0001477932-24-005128.txt	Edgar Link	pending
0001477932-24-005128-xbrl.zip	Edgar Link	pending
aspi-20240630.xsd	Edgar Link	pending
aspi_10q.htm	Edgar Link	pending
aspi_ex311.htm	Edgar Link	pending
aspi_ex312.htm	Edgar Link	pending
aspi_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
aspi-20240630_def.xml	Edgar Link	unprocessable
aspi-20240630_lab.xml	Edgar Link	unprocessable
aspi-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aspi_10q_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aspi-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASPI
ASP Isotopes Inc. Stock $aspi

2024 Q3 Form 10-Q Financial Statement

#000147793224005128 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASPI ASP Isotopes Inc. Stock $aspi

2024 Q3 Form 10-Q Financial Statement

#000147793224005128 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASPI
ASP Isotopes Inc. Stock $aspi